more

Innoviva (INVA)

(Real Time Quote from BATS)

$20.15 USD

-0.03 (-0.15%)

Updated Nov 11, 2024 02:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth C Momentum C VGM

Industry Rank:

Top 23% (57 out of 250)

Industry: Large Cap Pharmaceuticals

View All Zacks #1 Ranked Stocks

Zacks News

Sail Through the Choppy Market With These 4 Low-Beta Stocks

by Nilanjan Banerjee Published on March 04,2022

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), Innoviva (INVA), Horace (HMN) and Maravai LifeSciences (MRVI) are well poised to gain.

Can Innoviva (INVA) Run Higher on Rising Earnings Estimates?

by Zacks Equity Research Published on February 24,2022

Innoviva (INVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

INVANegative Net Change

Is Innoviva (INVA) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research Published on February 24,2022

Here is how Innoviva (INVA) and Phibro Animal Health (PAHC) have performed compared to their sector so far this year.

Moving Average Crossover Alert: Innoviva

by Zacks Equity Research Published on March 08,2021

Innoviva (INVA) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

INVANegative Net Change

biotechs

What's in Store for Innoviva (INVA) This Earnings Season?

by Zacks Equity Research Published on February 02,2021

Strong demand for Glaxo's Trelegy Ellipta is likely to have driven royalties for Innoviva (INVA) in the fourth quarter.

pharmaceuticals

Innoviva (INVA) Gains As Market Dips: What You Should Know

by Zacks Equity Research Published on January 26,2021

In the latest trading session, Innoviva (INVA) closed at $12.51, marking a +1.71% move from the previous day.

INVANegative Net Change

Top Ranked Value Stocks to Buy for January 5th

by Zacks Equity Research Published on January 05,2021

Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 5th.

Top Ranked Value Stocks to Buy for January 4th

by Zacks Equity Research Published on January 04,2021

Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 4th

Should Value Investors Buy Innoviva (INVA) Stock?

by Zacks Equity Research Published on January 01,2021

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.